Nancy Ghattas
.jpg/jcr:content/renditions/cq5dam.web.320.Nancy Pic (002).jpg)
Vice President, Head of Immuno-Oncology and Gastrointestinal (GI) Cancers Franchise
Responsibilities
Nancy Ghattas, Vice President, Head of Immuno-Oncology and Gastrointestinal Cancers Franchise, US Oncology Business Unit, is responsible for overseeing all commercial and cross-functional team efforts in the US for IMFINZI, IMJUDO and future immuno-oncology assets and indications across multiple tumors, and all oncology assets in GI cancers.
Prior Experience
Nancy joined AstraZeneca in 2020 as the Vice President, Global Commercial Respiratory Biologics, Tezspire and joined the US Oncology Business Unit in 2023 as the Vice President, US Commercial Franchise Head of DNA Damage Repair, Gynecological and Genitourinary Cancer Franchise. Prior to joining AZ, Nancy was with Allergan as the Country President of UK and Ireland. Earlier in her career, she spent 14 years building a wealth of experience in commercial and strategy roles at Merck/MSD in the US and the Middle East.
Education
- Bachelor of Science (BS), Pharmacy and Pharmaceutical Sciences, Cairo University – Cairo, Egypt
.jpg)
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
Use a maximum of two downloads here